# | Website | Score in June 2020 | 1m changes |
---|
1 | Global, regional, and national age–sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for t... | 929 | +148 |
2 | Parkinson’s Disease: Genetics and Pathogenesis | 525 | +325 |
3 | Alzheimer’s disease | 384 | -672 |
4 | Indoor air pollution: a public health perspective | 316 | -367 |
5 | History of Ancient Copper Smelting Pollution During Roman and Medieval Times Recorded in Greenland Ice | 316 | -367 |
6 | Prevention and treatment of the common cold: making sense of the evidence | 217 | -109 |
7 | Cholera | 215 | -123 |
8 | Alzheimer’s disease | 192 | -336 |
9 | A Systematic Literature Review of Twitter Research from a Socio-Political Revolution Perspective | 160 | +80 |
10 | Does This Patient Have Influenza? | 117 | -16 |
11 | Management of Influenza in Adults Older than 65 Years of Age: Cost-Effectiveness of Rapid Testing and Antiviral Therapy | 117 | -16 |
12 | The global implications of diabetes and cancer | 114 | -114 |
13 | Acute Diarrhea in Children | 112 | +62 |
14 | Cancer is a Preventable Disease that Requires Major Lifestyle Changes | 81 | -24 |
15 | American Cancer Society guidelines on nutrition and physical activity for cancer prevention | 81 | -24 |
16 | 16. The fraction of cancer attributable to lifestyle and environmental factors in the UK in 2010 | 81 | -24 |
17 | Screening for breast cancer with mammography | 81 | -24 |
18 | Nonmelanoma Skin Cancer | 81 | -24 |
19 | Epidemiology and Economic Burden of Nonmelanoma Skin Cancer | 81 | -24 |
20 | Global cancer statistics | 81 | -24 |
21 | Understanding the symptoms of the common cold and influenza | 72 | -26 |
22 | Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Stud... | 66 | -34 |
23 | Transmission of influenza A in human beings | 58 | -8 |
24 | Physical interventions to interrupt or reduce the spread of respiratory viruses | 58 | -8 |
25 | The Value of Neuraminidase Inhibitors for the Prevention and Treatment of Seasonal Influenza: A Systematic Review of Systematic Reviews | 58 | -8 |
26 | Hyperglycemic Crises in Adult Patients With Diabetes | 57 | -57 |
27 | The clinical effectiveness and cost-effectiveness of bariatric (weight loss) surgery for obesity: a systematic review and economic evaluation | 57 | -57 |
28 | Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease St... | 57 | -57 |
29 | Economic Costs of Diabetes in the U.S. in 2012 | 57 | -57 |
30 | What is Type 1 Diabetes? | 57 | -57 |
31 | CLINICAL ASPECTS OF UNCOMPLICATED AND SEVERE MALARIA | 52 | -12 |
32 | Alzheimer’s Disease | 48 | -84 |
33 | Survival in dementia and predictors of mortality: a review | 48 | -84 |
34 | Exercise programs for people with dementia | 48 | -84 |
35 | The common cold | 43 | -22 |
36 | Non-steroidal anti-inflammatory drugs for the common cold | 43 | -22 |
37 | Appropriate Antibiotic Use for Acute Respiratory Tract Infection in Adults: Advice for High-Value Care From the American College of Physicians and the... | 43 | -22 |
38 | Malaria: | 39 | -9 |
39 | Effectiveness of oseltamivir in adults: a meta-analysis of published and unpublished clinical trials | 29 | -4 |
40 | Acute Fever and Petechial Rash Associated with Influenza A Virus Infection | 29 | -4 |
41 | Influenza in children | 29 | -4 |
42 | GASTRIC ’FLU INFLUENZA B CAUSING ABDOMINAL SYMPTOMS IN CHILDREN | 29 | -4 |
43 | Review of clinical symptoms and spectrum in humans with influenza A/H5N1 infection | 29 | -4 |
44 | Clinical Signs and Symptoms Predicting Influenza Infection | 29 | -4 |
45 | Cost-effectiveness of newer treatment strategies for influenza | 29 | -4 |
46 | Is malaria a disease of poverty? A review of the literature | 26 | -6 |
47 | Malaria | 26 | -6 |
48 | Rapid diagnostic tests for diagnosing uncomplicated P. falciparum malaria in endemic countries | 13 | -3 |
49 | Response to Malaria Epidemics in Africa | 13 | -3 |
50 | Quinine, an old anti-malarial drug in a modern world: role in the treatment of malaria | 13 | -3 |
51 | Laboratory diagnosis of malaria in nonhuman primates | 13 | -3 |
52 | Understanding the population genetics of Plasmodium vivax is essential for malaria control and elimination | 13 | -3 |
53 | Spread of Artemisinin Resistance in Plasmodium falciparum Malaria | 13 | -3 |
54 | Anopheles gambiaeGenome: Completing the Malaria Triad | 13 | -3 |
55 | Malaria zoonoses | 13 | -3 |
56 | Evidence and Implications of Mortality Associated with Acute Plasmodium vivax Malaria | 13 | -3 |
57 | Intermittent preventive treatment of malaria in pregnant women and infants: making best use of the available evidence | 13 | -3 |
58 | Redefining cerebral malaria by including malaria retinopathy | 13 | -3 |
59 | The therapeutic potential of metal-based antimalarial agents: Implications for the mechanism of action | 13 | -3 |
60 | Malaria Primer for Clinicians in the United States | 13 | -3 |
61 | History of malaria research and its contribution to the malaria control success in Suriname: a review | 13 | -3 |
62 | Substandard medicines in resource-poor settings: a problem that can no longer be ignored | 13 | -3 |
63 | Plasmodium knowlesi:Finally Being Recognized | 13 | -3 |
64 | Plasmodium knowlesi: A Malaria Parasite of Monkeys and Humans | 13 | -3 |
65 | The cellular and molecular basis for malaria parasite invasion of the human red blood cell | 13 | -3 |
66 | History of Human Parasitology | 13 | -3 |
67 | Advances and challenges in malaria vaccine development | 13 | -3 |
68 | Malaria in the Greater Mekong Subregion: Heterogeneity and complexity | 13 | -3 |
69 | Artemisinin resistance: current status and scenarios for containment | 13 | -3 |
70 | Thiamin (Vitamin B1) Biosynthesis and Regulation: A Rich Source of Antimicrobial Drug Targets? | 13 | -3 |
71 | Electronic mosquito repellents for preventing mosquito bites and malaria infection | 13 | -3 |
72 | Malaria Management: Past, Present, and Future | 13 | -3 |
73 | Artemisinin-Resistant Malaria: Research Challenges, Opportunities, and Public Health Implications | 13 | -3 |
74 | Shrinking the malaria map: progress and prospects | 13 | -3 |
75 | The ’hidden’ burden of malaria: cognitive impairment following infection | 13 | -3 |
76 | Chemoprophylaxis in malaria: drugs, evidence of efficacy and costs | 13 | -3 |
77 | Malaria Prevention in Short-Term Travelers | 13 | -3 |
78 | A new world malaria map: Plasmodium falciparum endemicity in 2010 | 13 | -3 |
79 | Vaccines for preventing malaria (SPf66) | 13 | -3 |
80 | Malaria in 2002 | 13 | -3 |
81 | Spurious and counterfeit drugs: a growing industry in the developing world | 13 | -3 |
82 | European Vaccine Initiative: lessons from developing malaria vaccines | 13 | -3 |
83 | Vaccines for preventing malaria (blood-stage) | 13 | -3 |
84 | Assembling a global database of malaria parasite prevalence for the Malaria Atlas Project | 13 | -3 |
85 | The Changing Disease-Scape in the Third Epidemiological Transition | 13 | -3 |
86 | The impact of maternal malaria on newborns | 13 | -3 |
87 | Estimating the Global Clinical Burden of Plasmodium falciparum Malaria in 2007 | 13 | -3 |
88 | Population genetics of malaria resistance in humans | 13 | -3 |
89 | Vaccines against malaria | 13 | -3 |
90 | Development of a metabolically active, non-replicating sporozoite vaccine to preventPlasmodium falciparummalaria | 13 | -3 |
91 | Technologies for global health | 13 | -3 |
92 | Reflections on the ’discovery’ of the antimalarial qinghao | 13 | -3 |
93 | Cerebral Malaria: Mechanisms of Brain Injury and Strategies for Improved Neurocognitive Outcome | 13 | -3 |
94 | Transgenic anopheline mosquitoes impaired in transmission of a malaria parasite | 13 | -3 |
95 | Drugs for preventing malaria in travellers | 13 | -3 |
96 | Malaria, Plasmodium falciparum and its apicoplast | 13 | -3 |
97 | Systematic review and meta-analysis: rapid diagnostic tests versus placental histology, microscopy and PCR for malaria in pregnant women | 13 | -3 |
98 | The Quest for Quinine: Those Who Won the Battles and Those Who Won the War | 13 | -3 |
99 | Dihydroartemisinin/Piperaquine | 13 | -3 |
100 | Eradication of Anopheles gambiae from Brazil: lessons for malaria control in Africa? | 13 | -3 |
101 | Ongoing challenges in the management of malaria | 13 | -3 |
102 | Malaria Attributable to the HIV-1 Epidemic, Sub-Saharan Africa | 13 | -3 |
103 | How Malaria Has Affected the Human Genome and What Human Genetics Can Teach Us about Malaria | 13 | -3 |
104 | Discoverers of quinine | 13 | -3 |
105 | Malaria in adolescence: burden of disease, consequences, and opportunities for intervention | 13 | -3 |
106 | Global malaria mortality between 1980 and 2010: a systematic analysis | 13 | -3 |
107 | Ecology and conservation biology of avian malaria | 13 | -3 |
108 | Insecticide-treated bed nets and curtains for preventing malaria | 13 | -3 |
109 | Counterfeit and substandard antimalarial drugs in Cambodia | 13 | -3 |
110 | The use of remotely sensed environmental data in the study of malaria | 13 | -3 |
111 | A systematic review of the safety and efficacy of artemether-lumefantrine against uncomplicated Plasmodium falciparum malaria during pregnancy | 13 | -3 |
112 | Molecular interactions in the placenta during malaria infection | 13 | -3 |
113 | Intermittent preventive treatment for malaria in children living in areas with seasonal transmission | 13 | -3 |
114 | Antipyretic measures for treating fever in malaria | 13 | -3 |
115 | Estimating the Number of Insecticide-Treated Nets Required by African Households to Reach Continent-wide Malaria Coverage Targets | 13 | -3 |
116 | Transgenic RodentPlasmodium bergheiParasites as Tools for Assessment of Functional Immunogenicity and Optimization of Human Malaria Vaccines | 13 | -3 |
117 | Plasmodium malariae and Plasmodium ovale – the ‘bashful’ malaria parasites | 13 | -3 |
118 | Vitamin B metabolism in Plasmodium falciparum as a source of drug targets | 13 | -3 |
119 | Poor-quality antimalarial drugs in southeast Asia and sub-Saharan Africa | 13 | -3 |
120 | Counterfeit anti-infective drugs | 13 | -3 |
121 | A Collaborative Epidemiological Investigation into the Criminal Fake Artesunate Trade in South East Asia | 13 | -3 |
122 | Insecticide-treated net coverage in Africa: mapping progress in 2000–07 | 13 | -3 |
123 | Recent clinical and molecular insights into emerging artemisinin resistance in Plasmodium falciparum | 13 | -3 |
124 | Management of Severe Malaria: Results from Recent Trials | 13 | -3 |
125 | Transfusion‐Transmitted Malaria in Countries Where Malaria Is Endemic: A Review of the Literature from Sub‐Saharan Africa | 13 | -3 |
126 | WHO combats counterfeit malaria drugs in Asia | 13 | -3 |
127 | MOSQUITO BEHAVIOR AND VECTOR CONTROL | 13 | -3 |
128 | Working without a blindfold: the critical role of diagnostics in malaria control | 13 | -3 |
129 | Indoor residual spraying for preventing malaria | 13 | -3 |
130 | A Fresh Look at the Origin of Plasmodium falciparum, the Most Malignant Malaria Agent | 13 | -3 |
131 | Malaria vector control: from past to future | 13 | -3 |
132 | Cerebral malaria | 13 | -3 |
133 | SOCIAL IMPLICATIONS OF MALARIA AND THEIR RELATIONSHIPS WITH POVERTY | 13 | -3 |
134 | What is the evidence for the existence of Plasmodium ovale hypnozoites? | 13 | -3 |
135 | Malaria in pregnancy in the Asia-Pacific region | 13 | -3 |
136 | Immune mechanisms in malaria: new insights in vaccine development | 13 | -3 |
137 | Ferrocene-based antimalarials | 13 | -3 |
138 | Costs and financial feasibility of malaria elimination | 13 | -3 |
139 | The economic and social burden of malaria | 13 | -3 |
140 | Malaria and Rome | 13 | -3 |
141 | Critical Care Aspects of Malaria | 13 | -3 |
142 | Artesunate versus quinine for treating severe malaria | 13 | -3 |
143 | Challenges of drug-resistant malaria | 13 | -3 |
144 | Respiratory Manifestations of Malaria | 13 | -3 |
145 | The Plasmodium falciparum-infected red blood cell | 13 | -3 |
146 | Clinical review: Severe malaria | 13 | -3 |
147 | Systems immunology of human malaria | 13 | -3 |
148 | Drug Resistance in Plasmodium: Natural Products in the Fight Against Malaria | 13 | -3 |
149 | Mosquito larval source management for controlling malaria | 13 | -3 |
150 | Global Status of DDT and Its Alternatives for Use in Vector Control to Prevent Disease | 13 | -3 |
151 | Reflections on early malaria vaccine studies, the first successful human malaria vaccination, and beyond | 13 | -3 |
152 | Malaria Parasite Pre-Erythrocytic Stage Infection: Gliding and Hiding | 13 | -3 |
153 | The Forgotten Malaria | 13 | -3 |
154 | Genetic variation and susceptibility to infection: the red cell and malaria | 13 | -3 |
155 | Qinghaosu (Artemisinin): The Price of Success | 13 | -3 |
156 | Determinants of relapse periodicity in Plasmodium vivax malaria | 13 | -3 |
157 | Malaria Eradication in the United States | 13 | -3 |
158 | Malaria Rapid Diagnostic Tests | 13 | -3 |
159 | Declining Artesunate-Mefloquine Efficacy against Falciparum Malaria on the Cambodia–Thailand Border | 13 | -3 |
160 | Malaria control in Bhutan: case study of a country embarking on elimination | 13 | -3 |
161 | 10.1353/smx.2007.0045 | 10 | -547 |